Ewch i’r prif gynnwys
Ysgol Cemeg

Newyddion

Mae'r cynnwys hwn ar gael yn Saesneg yn unig.

Biophotonic Nanoswitches

Light triggers death switch in cancer cells

28 Ionawr 2014

Recent internationally leading research has been highlighted in the media.

Mass spectometry

Technology investment broadens Chemistry’s spectrum

16 Ionawr 2014

Industry partners to benefit from new chemical analysis suite.

Computational Chemistry LIVE

Computational Chemistry LIVE

19 Rhagfyr 2013

As part of chemistry week the School of Chemistry hosted a CHEMNET outreach afternoon entitled “Computational Chemistry LIVE.

Chemistry mass spectrometry suite

New mass spectrometry suite for School of Chemistry

18 Rhagfyr 2013

The School of Chemistry is set to benefit from a major EPSRC investment in a state of the art mass spectrometry suite.

Royal society honours cardiff

Royal Society honours Cardiff scientists

12 Rhagfyr 2013

Professors Graham Hutchings and Peter Wells recognised for research achievements

Light triggers death switch in cancer cells

It’s a knock-in

4 Rhagfyr 2013

New research from the School of Chemistry has advanced our understanding of how enzymes (proteins) increase the rate of chemical reactions.

Cardiff University

School of Chemistry awarded a new Centre for Doctoral Training in Catalysis

22 Tachwedd 2013

Cardiff benefits as Willetts announces £350M for postgraduate study

cancer death switch

Light triggers cancer death switch

16 Hydref 2013

Light pulses stimulate designer peptides to initiate a death pathway in cancerous cells.

Biophotonic Nanoswitches control the life cycle of cells

9 Hydref 2013

Researchers from Cardiff University’s School of Chemistry along with their colleagues from the Schools of Medicine and Pharmacy have created light-responsive peptides that are able to induce cell death in cancer cells when activated with externally applied light pulses.

Enzyme catalysis

Enzyme catalysis unravelled in new research

4 Hydref 2013

Research clears the way for designer enzymes with potential to develop anti-infective and anti-cancer drugs.